Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves new Allegra formulations

March 1, 2000

Zambon presents new PDE4 inhibitors useful for respiratory diseases

Feb. 29, 2000

Discovery to develop aerosolized formulations of Surfaxin

Feb. 28, 2000

New respiratory therapeutics from Zambon act as phosphodiesterase inhibitors

Feb. 28, 2000

PathoGenesis announces approval, distribution agreement for TOBI

Feb. 25, 2000

New treatment for COPD from Ono to enter clinical trials soon

Feb. 24, 2000

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

Feb. 23, 2000

Development of cystic fibrosis therapy advances at SciClone

Feb. 17, 2000

Antiallergic agents from SB act as CCR3 receptor antagonists

Feb. 16, 2000

Neurokinin antagonists in early development at AstraZeneca

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...